Antigen carbohydrate 125 as a prognostic biomarker in patients with stable chronic heart failure
In patients with stable chronic HFrEF, higher plasma CA125 was associated with an increase in the burden of mid-term morbidity and mortality. CA125 could be a surrogate marker of residual congestion and inflammatory activity in this particular scenario.
Authors
- M.J. Gómez Martínez
- Nuria Vicente Ibarra
- Paula Guedes Ramallo
- Andrea Romero Valero (ORCID: https://orcid.org/0000-0003-1339-2552)
- Pedro Morillas Blasco
- Jesús Castillo Castillo
- Alejandro Martínez-Rodríguez
- Julio Núñez Villota
- Marina Martínez Moreno
- Antonio García Honrubia
Institutions
- Universitat de València (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
Publication Details
- Journal
- Cardiovascular Diagnosis and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/cdt-2025-244
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00